The in vitro effects of galactose and its derivatives on rat brain Mg2+-ATPase activity

Pharmacology and Toxicology

Volumn 91, Issue 5, 2002, Pages 254-257

  Tsakiris, Stylianos ^a   Marinou, Kyriakoula ^a   Schulpis, Kleopatra H ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTITOL; GALACTOSE; GLUCOSE 1 PHOSPHATE; ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); GALACTOSE 1 PHOSPHATE; GALACTOSE PHOSPHATE; GALACTOSE-1-PHOSPHATE; GLUCOSE; GLUCOSE PHOSPHATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN HOMOGENATE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; ANIMAL; BRAIN; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; METABOLISM; SUCKLING; WISTAR RAT;

ANIMALIA;

ANIMALS; ANIMALS, SUCKLING; BRAIN; CA(2+) MG(2+)-ATPASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; GALACTITOL; GALACTOSE; GALACTOSEPHOSPHATES; GLUCOSE; GLUCOSEPHOSPHATES; MALE; RATS; RATS, WISTAR;

EID: 0036851503     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910506.x     Document Type: Article

References (17)

1. Berry, G. T. & S. Segal: Disorder of galactose metabolism. In: The Metabollic and Molecular Basis of Inherited Diseases. Eds.: C. R. Scriver, A. L. Beadet, W. S. Sly, D. Valle. McGraw Hill, New York, 2000, pp. 1553-1589.
2. 13C galactose in patients with galactose-1-phosphate uridyltransferase deficiency. Biochem. Mol. Med. 1995, 56, 158-165.
3. Bowler, K. & R. Tirri: The temperature characteristics of synaptic membrane ATPases from immature and adult rat brain. J. Neurochem. 1974, 23, 611-613.
4. Committee on Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animals Resources, National Research Council, Washington DC, 1985, p. 83.
5. 2+-ATPases of smooth muscle and brain. Arch. Biochem. Biophys. 1993, 303, 32-43.
6. Gitzelmann, R.: Galactose-1-phosphate in the pathophysiology of galactosemia. Eur. J. Pediatr. 1995, 154, S45-S49.
7. Leslie, N. D., K. L. Yager, B. D. McNamara & S. Segal: A mouse model of galactose-1-phosphate uridyltransferase deficiency. Biochem. Mol. Med. 1996, 59, 7-12.
8. Lowry, O. H., N. J. Rosebrough, A. L. Farr & A. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
9. Quan-Ma, R., H. Wells, W. Wells, F. Sherman & T. Egan: Galactitol in tissues of galactosemic child. Amer. J. Dis. Child. 1966, 112, 477-478.
10. Sanui, H. & H. Rubin: The role of magnesium in cell proliferation and transformation. In: Ions, Cell Proliferation and Cancer. Eds.: A. L. Boyton, W. L. McKeehan, J. P. Whitfield. Academic Press, New York, 1982, pp. 517-537.
11. Schulpis, K. H., E. D. Papakonstantinou, H. Michelakakis H & Shin Yoon: Screening for galactosemia in Greece. Paediatr. Perinatal. Epidemiol. 1997, 11, 436-440.
12. Segal, S.: Galactosemia today; the enigma and the challenge. J. Inher. Metab. Dis. 1998, 45, 455-457.
13. +-ATPase activities in adult and aged rat brain. Mech. Ageing Dev. 2001, 122, 491-501.
14. Tsakiris, S. & K. H. Schulpis: The effect of galactose metabolic disorders on rat brain acetylcholinesterase activity. Z. Naturforsch. 2000, 55c, 852-855.
15. Wells, R. J. & S. Segal: Galactose toxicity in the chick: Oxidation of radioactive galactose. Biochem. Biophys. Acta 1970, 222, 327-329.
16. Wilson, D. & D. Hogness: The enzymes of the galactose operon in E.coli III. The size and compound of galactokinase. J. Biol. Chem. 1969, 244, 2137-2140
17. 2+-ATPase in neurotransmitter release, using benzhydryl piperazines. Arch. Int. Pharmacodyn. Ther. 1979, 24, 4-15.